Utpal Koppikar - Mar 16, 2022 Form 3 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Mar 16, 2022
Transactions value $
$0
Form type
3
Date filed
3/17/2022, 04:19 PM
Previous filing
Mar 3, 2022
Next filing
May 19, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney